Thyroid cancer thyroid carcinoma
Conditions
Interventions
None listed
Sponsors
Universitair Medisch Centrum Utrecht
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: All of the following criteria: * The patient has provided written informed consent authorization before participating in the study * Cytologic diagnosis of differentiated thyroid carcinoma (Bethesda 6) and will undergo a hemi- or total thyroidectomy, or cytologic diagnosis of medullary thyroid carcinoma(Bethesda 6) * The patient is *18 years of age at time of consent * The patient has an ECOG status of Grade 0 * 2
Exclusion criteria
Exclusion criteria: Any of the following criteria: * The patient is incapacitated * The patient is pregnant or lactating * The patient has a history of neck dissection, gross injury or radiotherapy to the neck that would preclude reasonable surgical dissection for this trial * The patient will undergo minimally invasive thyroid surgery (via the axilla or trans-oral approach) * The patient is actively receiving systemic cytotoxic chemotherapy. * The patient is on immunosuppressive, anti-monocyte, or immunomodulatory therapy * The patient has a preoperatively histologically proven multifocal tumor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| * Number of SLNs determined on PET/CT * Number of resected SLNs | — |
Secondary
| Measure | Time frame |
|---|---|
| * Localization of SLNs * Pathology result of SLN compared to pathology result of rest of lymph node level * Optimal scan protocol * Surgical time * Questionnaire directed to the surgeon about complexity, feasibility and additional value of various identification methods for SLNs | — |
Countries
Netherlands
Outcome results
None listed